An elusive receptor is finally caught: P2Y 12 , an important drug target in platelets

Author： Barnard E.A.   Simon J.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.8, 2001-08, pp. : 388-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of P2Y<sub>12</sub> Receptor and Activated Platelets During Inflammation

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 720-728

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet P2Y 12 Receptor Inhibition: An Update on Clinical Drug Development

By Vivas David   Angiolillo Dominick J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 217-226

Adis International

Access to resources Recommend Favorite

Biology and Pharmacology of the Platelet P2Y12 Receptor

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1255-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet P2Y12 receptor inhibition by thienopyridines: status and future

By Porto Italo   Giubilato Simona   De Maria Giovanni Luigi   Biasucci Luigi Marzio   Crea Filippo  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1317-1332

Informa Healthcare

Access to resources Recommend Favorite

P2Y 12 ADP receptor antagonists after percutaneous coronary interventions P2Y 12 -ADP-Rezeptorantagonisten nach perkutanen Koronarinterventionen

By Trenk Dietmar  

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 53-60

Govi-Verlag

Access to resources Recommend Favorite